We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Dietary Flaxseed Slows Tumor Growth in Mouse Model

By LabMedica International staff writers
Posted on 20 Apr 2009
Results obtained from experiments with mice prone to development of intestinal tumors showed that a diet enriched with flaxseed meal or oil decreased the number and size of tumors as compared to animals whose diets were supplemented with corn meal or oil.

Flaxseed is the richest plant source of lignan precursors, which are important because the lignans that mammals produce from this food precursor have been shown to be protective against breast and colon cancer. More...
Furthermore, flaxseed contains secoisolariciresinol diglucoside (SDG), a potent antioxidant and a known precursor of the mammalian lignans, enterolactone and enterodiol. These compounds have other pharmacological properties including phytoestrogen properties similar to isoflavones.

In the current study investigators at South Dakota State University (Brookings, USA) chose to investigate the possible chemopreventive effects of dietary flaxseed on the development of intestinal tumors in ApcMin mice, a strain that develops spontaneous intestinal tumors due to a mutation.

To this end they separated ApcMin mice into five different groups, which were fed with control (AIN-93M meal), corn meal, flaxseed meal, corn oil, or flaxseed oil supplemented diets.

Results published in the March 2, 2009, issue of the journal Nutrition and Cancer showed that dietary flaxseed significantly decreased the number and size of tumors in the small intestine and colon as compared to control, corn-treated groups. Intestine, colon, and serum samples of corn-treated groups showed higher levels of omega -6 fatty acids, whereas the flaxseed treated groups exhibited higher levels of omega -3 fatty acids. Lignans were detected in the serum, intestine, and colon samples from the flaxseed meal group. Colon samples from the flaxseed meal group showed significantly lower expression of the enzymes COX-1 and COX-2 as compared to similar samples from the corn meal group.

"Results indicated that mice on diets supplemented with flaxseed meal and flaxseed oil had, on average, 45% fewer tumors in the small intestine and the colon compared to the control group," said senior author Dr. Chandradhar Dwivedi, professor of pharmaceutical sciences at South Dakota State University. "Dietary flaxseed oil and meal are effective chemopreventive agents against colon and intestinal tumor development in experimental animal models. Further studies are needed to establish the optimal amount of flaxseed that should be incorporated into human diets to get an antitumor benefit and to explore the possible mechanism of action by which flaxseed can help prevent colon cancer."

Related Links:
South Dakota State University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automated Urinalysis Solution
UN-9000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.